Making the Grade: Studies show promising results for CyclASol, a new medication to treat DED that could be approved next year

Authors :: Karpecki, Paul M.
Source :: Review of Optometry. November 15, 2022, Vol. 159 Issue 11, p88, 2 p.
Publication Year :: 2022
Abstract: Although the market may be saturated with dry eye disease (DED) treatments, there is a new medication with the potential to separate itself from the rest. Last month the FDA [...]

Subjects :: Dry eye syndromes -- Drug therapy
Ophthalmic solutions -- Dosage and administration -- Licensing, certification and accreditation -- Testing
Cyclosporine -- Dosage and administration -- Licensing, certification and accreditation -- Testing
Health

Tools